Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

VENUS REMEDIES LTD.

NSE : VENUSREMBSE : 526953ISIN CODE : INE411B01019Industry : Pharmaceuticals & DrugsHouse : Private

BSE1675.0072.75 (+4.54 %)

PREV CLOSE ( ) 1602.25

OPEN PRICE ( ) 1578.00

BID PRICE (QTY) 1670.35 (317)

OFFER PRICE (QTY) 1676.95 (324)

VOLUME 33973

TODAY'S LOW / HIGH ( )1577.65 1682.35

52 WK LOW / HIGH ( )417.65 1729.95

NSE1671.0060.3 (+3.74 %)

PREV CLOSE( ) 1610.70

OPEN PRICE ( ) 1571.00

BID PRICE (QTY) 1671.10 (6)

OFFER PRICE (QTY) 1673.40 (6)

VOLUME 245301

TODAY'S LOW / HIGH( ) 1571.00 1691.20

52 WK LOW / HIGH ( )416 1736.9

Quarters

Select year

( in Million)

Particulars

Mar 2026

Dec 2025

Sep 2025

Jun 2025

Audited / UnAudited

UnAudited

Net Sales

2594

1802.6

1927.5

1319

Total Expenditure

1959.7

1427.4

1617.9

1218

PBIDT (Excl OI)

634.3

375.2

309.6

101

Other Income

49.5

25.2

17.1

86.9

Operating Profit

683.8

400.4

326.7

187.9

Interest

0.1

Exceptional Items

0.00

PBDT

683.7

400.3

326.6

187.8

Depreciation

67.6

65.6

61.7

61.8

Profit Before Tax

616.1

334.7

264.9

126

Tax

141.2

78.9

63.6

Provisions and contingencies

Profit After Tax

474.9

255.8

201.3

96.00

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

474.9

255.8

201.3

96.00

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

474.9

255.8

201.3

Equity Capital

133.7

Face Value (IN RS)

Reserves

Calculated EPS

35.51

19.13

15.05

7.18

Calculated EPS (Annualised)

142.07

76.52

60.22

28.72

No of Public Share Holdings

7784991

% of Public Share Holdings

58.24

PBIDTM% (Excl OI)

24.45

20.81

16.06

7.65

PBIDTM%

26.36

22.21

16.94

14.24

PBDTM%

26.35

22.20

16.94

14.23

PBTM%

23.75

18.56

13.74

9.55

PATM%

18.30

14.19

10.44

7.27

Notes

Risk Disclosures on Derivatives

Quarterly Results

VENUS REMEDIES LTD.